Literature DB >> 23815500

Oxidized fatty acids: A potential pathogenic link between fatty liver and type 2 diabetes in obese adolescents?

Nicola Santoro1, Sonia Caprio, Cosimo Giannini, Grace Kim, Romy Kursawe, Bridget Pierpont, Melissa M Shaw, Ariel E Feldstein.   

Abstract

In this study, we sought to investigate the putative association of the oxidized metabolites derived from linoleic acid (OXFAs) with pediatric nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes (T2D). We studied 80 obese adolescents (age 13.3 ± 3.31 years; body mass index 33.0 ± 6.79 kg/m(2)), who underwent an oral glucose tolerance test, a magnetic resonance imaging (MRI) to measure the hepatic fat content, and the measurement of OXFAs and caspase-cleaved Citokeratin18 fragment (CK-18), a robust biomarker of liver injury. In this study, we show that only in subjects with hepatic steatosis, the OXFAs are associated with the CK-18 and that this association is modulated by the PNPLA3 rs738409 variant. We also show that most of the OXFAs are associated with a lower insulin secretion and that adolescents with T2D have higher levels of OXFAs than subjects with impaired or normal glucose tolerance. These observations lead to the hypothesis that the OXFAs may be the pathogenic link between liver injury and T2D and that the novel therapeutic opportunities targeting the OXFAs are possible in adolescents with early-onset NAFLD and T2D.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23815500      PMCID: PMC3887421          DOI: 10.1089/ars.2013.5466

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  9 in total

Review 1.  Metabolic syndrome in pediatrics: old concepts revised, new concepts discussed.

Authors:  Ebe D'Adamo; Nicola Santoro; Sonia Caprio
Journal:  Pediatr Clin North Am       Date:  2011-10       Impact factor: 3.278

2.  Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay.

Authors:  G Krey; O Braissant; F L'Horset; E Kalkhoven; M Perroud; M G Parker; W Wahli
Journal:  Mol Endocrinol       Date:  1997-06

3.  Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial.

Authors:  Claudia O Zein; Lisa M Yerian; Prema Gogate; Rocio Lopez; John P Kirwan; Ariel E Feldstein; Arthur J McCullough
Journal:  Hepatology       Date:  2011-08-24       Impact factor: 17.425

4.  Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Authors:  Ariel E Feldstein; Rocio Lopez; Tarek Abu-Rajab Tamimi; Lisa Yerian; Yoon-Mi Chung; Michael Berk; Renliang Zhang; Thomas M McIntyre; Stanley L Hazen
Journal:  J Lipid Res       Date:  2010-07-14       Impact factor: 5.922

5.  12-Lipoxygenase Products Reduce Insulin Secretion and {beta}-Cell Viability in Human Islets.

Authors:  K Ma; C S Nunemaker; R Wu; S K Chakrabarti; D A Taylor-Fishwick; J L Nadler
Journal:  J Clin Endocrinol Metab       Date:  2010-01-20       Impact factor: 5.958

6.  The plasma lipidomic signature of nonalcoholic steatohepatitis.

Authors:  Puneet Puri; Michelle M Wiest; Onpan Cheung; Faridoddin Mirshahi; Carol Sargeant; Hae-Ki Min; Melissa J Contos; Richard K Sterling; Michael Fuchs; Huiping Zhou; Steven M Watkins; Arun J Sanyal
Journal:  Hepatology       Date:  2009-12       Impact factor: 17.425

7.  Lowering dietary linoleic acid reduces bioactive oxidized linoleic acid metabolites in humans.

Authors:  Christopher E Ramsden; Amit Ringel; Ariel E Feldstein; Ameer Y Taha; Beth A MacIntosh; Joseph R Hibbeln; Sharon F Majchrzak-Hong; Keturah R Faurot; Stanley I Rapoport; Yewon Cheon; Yoon-Mi Chung; Michael Berk; J Douglas Mann
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2012-09-05       Impact factor: 4.006

8.  Hepatic fat accumulation is modulated by the interaction between the rs738409 variant in the PNPLA3 gene and the dietary omega6/omega3 PUFA intake.

Authors:  Nicola Santoro; Mary Savoye; Grace Kim; Katie Marotto; Melissa M Shaw; Bridget Pierpont; Sonia Caprio
Journal:  PLoS One       Date:  2012-05-21       Impact factor: 3.240

9.  Cellular production of n-3 PUFAs and reduction of n-6-to-n-3 ratios in the pancreatic beta-cells and islets enhance insulin secretion and confer protection against cytokine-induced cell death.

Authors:  Dong Wei; Jie Li; Miaoda Shen; Wei Jia; Nuoqi Chen; Tao Chen; Dongming Su; Haoming Tian; Shusen Zheng; Yifan Dai; Allan Zhao
Journal:  Diabetes       Date:  2009-11-23       Impact factor: 9.461

  9 in total
  14 in total

1.  Hepatic De Novo Lipogenesis in Obese Youth Is Modulated by a Common Variant in the GCKR Gene.

Authors:  Nicola Santoro; Sonia Caprio; Bridget Pierpont; Michelle Van Name; Mary Savoye; Elizabeth J Parks
Journal:  J Clin Endocrinol Metab       Date:  2015-06-04       Impact factor: 5.958

2.  Oxidized Derivatives of Linoleic Acid in Pediatric Metabolic Syndrome: Is Their Pathogenic Role Modulated by the Genetic Background and the Gut Microbiota?

Authors:  Domenico Tricò; Anna Di Sessa; Sonia Caprio; Naga Chalasani; Wanqing Liu; Tiebing Liang; Joerg Graf; Raimund I Herzog; Casey D Johnson; Giuseppina Rosaria Umano; Ariel E Feldstein; Nicola Santoro
Journal:  Antioxid Redox Signal       Date:  2017-04-07       Impact factor: 8.401

3.  Acute Changes in Non-esterified Fatty Acids in Patients with Type 2 Diabetes Receiving Bariatric Surgery.

Authors:  Reza Nemati; Jun Lu; Andrea Tura; Greg Smith; Rinki Murphy
Journal:  Obes Surg       Date:  2017-03       Impact factor: 4.129

Review 4.  Linoleic acid and the regulation of glucose homeostasis: A review of the evidence.

Authors:  Jakob S Hamilton; Eric L Klett
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2021-10-29       Impact factor: 4.006

Review 5.  Modulation of hepatic steatosis by dietary fatty acids.

Authors:  Alessandra Ferramosca; Vincenzo Zara
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

Review 6.  Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests.

Authors:  Mojgan Masoodi; Amalia Gastaldelli; Tuulia Hyötyläinen; Enara Arretxe; Cristina Alonso; Melania Gaggini; Julia Brosnan; Quentin M Anstee; Oscar Millet; Pablo Ortiz; Jose M Mato; Jean-Francois Dufour; Matej Orešič
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-09-10       Impact factor: 46.802

7.  The PNPLA3 Ile148Met interacts with overweight and dietary intakes on fasting triglyceride levels.

Authors:  Ivana A Stojkovic; Ulrika Ericson; Gull Rukh; Martin Riddestråle; Stefano Romeo; Marju Orho-Melander
Journal:  Genes Nutr       Date:  2014-02-22       Impact factor: 5.523

8.  The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH).

Authors:  Rohini Mehta; Kianoush Jeiran; Aaron B Koenig; Munkzhul Otgonsuren; Zachary Goodman; Ancha Baranova; Zobair Younossi
Journal:  BMC Med Genet       Date:  2016-09-05       Impact factor: 2.103

9.  From the liver to the heart: Cardiac dysfunction in obese children with non-alcoholic fatty liver disease.

Authors:  Anna Di Sessa; Giuseppina Rosaria Umano; Emanuele Miraglia Del Giudice; Nicola Santoro
Journal:  World J Hepatol       Date:  2017-01-18

10.  Linoleic Acid-Derived Oxylipins Differentiate Early Stage Alcoholic Hepatitis From Mild Alcohol-Associated Liver Injury.

Authors:  Dennis Warner; Vatsalya Vatsalya; Kara H Zirnheld; Jeffrey B Warner; Josiah E Hardesty; John C Umhau; Craig J McClain; Krishnarao Maddipati; Irina A Kirpich
Journal:  Hepatol Commun       Date:  2021-02-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.